These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10077769)

  • 21. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Helicobacter pylori.
    Bytzer P; O'Morain C
    Helicobacter; 2005; 10 Suppl 1():40-6. PubMed ID: 16178970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [First line therapy for Helicobacter pylori eradication in France].
    Dupas JL
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):467-72. PubMed ID: 12700504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Eradication of Helicobacter pylori and use of antisecretory drugs--a population based study].
    Lassen AT; Hallas J; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2004 Sep; 166(39):3405-7. PubMed ID: 15515395
    [No Abstract]   [Full Text] [Related]  

  • 27. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
    Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
    Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori eradication: therapy other than with bismuth or proton-pump inhibitors.
    Korman MG
    Scand J Gastroenterol Suppl; 1996; 220():41-3. PubMed ID: 8898434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current role of acid suppressants in the treatment of peptic ulcer disease].
    Takeda H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():371-6. PubMed ID: 11979809
    [No Abstract]   [Full Text] [Related]  

  • 31. Eradication of Helicobacter pylori and use of antisecretory drugs: population based cohort study.
    Lassen A; Hallas J; de Muckadell OB
    BMJ; 2003 Sep; 327(7415):603. PubMed ID: 12969930
    [No Abstract]   [Full Text] [Related]  

  • 32. Eradication of Helicobacter pylori: why does it fail?
    Deltenre M; Ntounda R; Jonas C; De Koster E
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S326-8. PubMed ID: 10077767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of antiinfectives.
    McLoughlin R; O'Morain C
    Chemotherapy; 2005 Aug; 51(5):243-6. PubMed ID: 16088120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Helicobacter pylori eradication. Triple or quadruple therapy?, Long or short treatment?].
    Calvet X; Gené E
    Gastroenterol Hepatol; 2003 May; 26(5):325-9. PubMed ID: 12732108
    [No Abstract]   [Full Text] [Related]  

  • 35. [Peptic ulcer recurrent in patients following successful eradication of Helicobacter pylori].
    Horiki N; Fujita Y; Maruyama M; Imoto I; Ogura A; Kuroda M; Nakamura M; Adachi Y
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():508-11. PubMed ID: 16363590
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of Helicobacter pylori infection. Whom to treat and with what?].
    Dehesa-Violante M
    Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):50-5. PubMed ID: 11464622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Continuation of acid suppression therapy after H. pylori eradication].
    Takahashi M; Kuwayama H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():531-5. PubMed ID: 11979841
    [No Abstract]   [Full Text] [Related]  

  • 38. "Modern therapies for Helicobacter pylori infection".
    Go MF
    Acta Gastroenterol Latinoam; 1996; 26(2):119-23. PubMed ID: 9137668
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antimicrobial sensitivity of Helicobacter pyloriø].
    López-Brea M
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():32-5. PubMed ID: 7914433
    [No Abstract]   [Full Text] [Related]  

  • 40. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication.
    Tan AC; Hartog GD; Mulder CJ
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1519-22. PubMed ID: 10571610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.